Intrinsiqs

Is Aardvark Therapeutics, Inc. Common Stock overvalued?

Aardvark Therapeutics, Inc. Common Stock (AARD) — key valuation metrics and fundamentals.

No verdict
Price
$6.54
Fair value
Current P/E
Normal P/E
Market cap
$143.1M
Dividend yield
0.0%
Return on equity
-61.7%
Sector
Healthcare

See the full interactive analysis →

Fair value compares AARD's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Aug 2026.